{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T06:24:47Z","timestamp":1745043887611},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotherapy"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1007\/bf02221327","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T14:41:29Z","timestamp":1128609689000},"page":"345-349","source":"Crossref","is-referenced-by-count":16,"title":["Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer"],"prefix":"10.1007","volume":"3","author":[{"given":"Kosei","family":"Yasumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02221327_CR1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","volume":"313","author":"SA Rosenberg","year":"1985","unstructured":"Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson CG, Reichert CM. Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485\u201392.","journal-title":"N Engl J Med"},{"key":"BF02221327_CR2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198704093161501","volume":"316","author":"SA Rosenberg","year":"1987","unstructured":"Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG,White DE. A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987; 316: 889\u2013905.","journal-title":"N Engl J Med"},{"key":"BF02221327_CR3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00000658-198910000-00008","volume":"210","author":"SA Rosenberg","year":"1989","unstructured":"Rosenberg SA, Lotze ML, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surgery 1989; 210: 474\u201385.","journal-title":"Ann Surgery"},{"key":"BF02221327_CR4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM198704093161502","volume":"316","author":"WH West","year":"1987","unstructured":"West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Okdham RK. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 1987; 316: 898\u2013905.","journal-title":"N Engl J Med"},{"key":"BF02221327_CR5","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4049\/jimmunol.130.5.2203","volume":"130","author":"JH Donohue","year":"1983","unstructured":"Donohue JH, Rosenberg SA. The fate of interleukin-2 afterin vivo administration. J Immunol 1983; 130: 2203\u20138.","journal-title":"J Immunol"},{"key":"BF02221327_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/bjc.1983.15","volume":"47","author":"C Bindon","year":"1983","unstructured":"Bindon C, Czerniecki M, Ruell P, Edwards A, McCarthy WH, Harris R, Hersey P. Clearance rates and systemic effects of intravenously administrated interleukin-2 (IL-2) containing preparations in human subjects. Br J Cancer 1983; 47: 123\u201333.","journal-title":"Br J Cancer"},{"key":"BF02221327_CR7","first-page":"561","volume":"3","author":"AE Hang","year":"1984","unstructured":"Hang AE, Hyatt CL, Rosenberg SA. Systemic administration of recombinant human interleukin-2 in mice. J Biol Response Modifiers 1984; 3: 561\u201372.","journal-title":"J Biol Response Modifiers"},{"key":"BF02221327_CR8","first-page":"2184","volume":"47","author":"K Yasumoto","year":"1987","unstructured":"Yasumoto K, Miyazaki K, Nagashima A, Ishida T, Kuda T, Yano T, Sugimachi K, Nomoto K. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. Cancer Res. 1987; 47: 2184\u20137.","journal-title":"Cancer Res."},{"key":"BF02221327_CR9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","volume":"193","author":"DA Morgan","year":"1976","unstructured":"Morgan DA, Ruscetti FW, Gallo R. Selectivein vitro growth of T lymphocytes from normal human bone marrows. Science (Wash DC) 1976; 193: 1007\u20138.","journal-title":"Science (Wash DC)"},{"key":"BF02221327_CR10","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.121.6.2168","volume":"121","author":"PE Baker","year":"1982","unstructured":"Baker PE, Gillis S, Ferm MM, Smith KA. The effect of T cell growth factor on the generation of cytolytic T cells. J Immunol 1982; 121: 2168\u201373.","journal-title":"J Immunol"},{"key":"BF02221327_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/291335a0","volume":"291","author":"CS Henney","year":"1981","unstructured":"Henney CS, Kuribayashi K, Kern DE, Gills S. Interleukin-2 augment natural killer cell activity. Nature (Lond.) 1981; 291: 335\u20138.","journal-title":"Nature (Lond.)"},{"key":"BF02221327_CR12","first-page":"4420","volume":"41","author":"MT Lotze","year":"1981","unstructured":"Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 1981; 41: 4420\u20135.","journal-title":"Cancer Res"},{"key":"BF02221327_CR13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grimm","year":"1982","unstructured":"Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823\u201341.","journal-title":"J Exp Med"}],"container-title":["Biotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02221327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02221327\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02221327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:31:18Z","timestamp":1683246678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02221327"}},"subtitle":["A multi-institutional cooperative study"],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["BF02221327"],"URL":"https:\/\/doi.org\/10.1007\/bf02221327","relation":{},"ISSN":["0921-299X","1573-8280"],"issn-type":[{"value":"0921-299X","type":"print"},{"value":"1573-8280","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}